GRST Stock Overview
Ethema Health Corporation, together with its subsidiaries, operates behavioral healthcare space specifically in the treatment of substance use disorders.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Ethema Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0003 |
52 Week High | US$0.0007 |
52 Week Low | US$0.0002 |
Beta | 2.25 |
1 Month Change | -25.00% |
3 Month Change | 0% |
1 Year Change | -25.00% |
3 Year Change | -94.74% |
5 Year Change | -99.55% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
GRST | US Healthcare | US Market | |
---|---|---|---|
7D | -14.3% | 0.6% | 1.0% |
1Y | -25.0% | 2.2% | 21.9% |
Price Volatility
GRST volatility | |
---|---|
GRST Average Weekly Movement | 41.2% |
Healthcare Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GRST's share price has been volatile over the past 3 months.
Volatility Over Time: GRST's weekly volatility has increased from 34% to 41% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 46 | Shawn Leon | ethemahealth.com |
Ethema Health Corporation, together with its subsidiaries, operates behavioral healthcare space specifically in the treatment of substance use disorders. The company operates through two segments, Rental Operations and In-Patient Services. It also operates addiction treatment centers.
Ethema Health Corporation Fundamentals Summary
GRST fundamental statistics | |
---|---|
Market cap | US$1.12m |
Earnings (TTM) | US$1.62m |
Revenue (TTM) | US$5.45m |
0.7x
P/E Ratio0.2x
P/S RatioIs GRST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GRST income statement (TTM) | |
---|---|
Revenue | US$5.45m |
Cost of Revenue | US$2.38m |
Gross Profit | US$3.07m |
Other Expenses | US$1.45m |
Earnings | US$1.62m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.00044 |
Gross Margin | 56.37% |
Net Profit Margin | 29.72% |
Debt/Equity Ratio | -87.5% |
How did GRST perform over the long term?
See historical performance and comparison